Literature DB >> 3368028

Regional brain GABA metabolism and release during hepatic coma produced in rats chronically treated with carbon tetrachloride.

M Díaz-Muñoz1, R Tapia.   

Abstract

Hepatic coma was induced in rats chronically treated with CCl4, by means of a single injection of ammonium acetate. The activities of glutamate decarboxylase (GAD) and GABA transaminase (GABA-T), as well as the synaptosomal uptake and release of [3H]GABA, were measured in the following brain areas of the comatose rats: cortex, striatum, hypothalamus, hippocampus, midbrain and cerebellum. Hepatic coma was associated with a general decrease of GAD activity, whereas GABA-T activity was diminished only in the hypothalamus, striatum and midbrain. During hepatic coma, the K+-stimulated [3H]GABA release was notably diminished in the striatum and cerebellum, whereas a significant increase was observed in the hippocampus. [3H]GABA uptake increased in most regions after CCl4 treatment, independently of the presence of coma. The results indicate that GABAergic transmission seems to be decreased in most cerebral regions during hepatic coma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368028     DOI: 10.1007/bf00971852

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

1.  Soluble gamma-aminobutyric-glutamic transaminase from Pseudomonas fluorescens.

Authors:  E M SCOTT; W B JAKOBY
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

2.  Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat.

Authors:  A M Mans; S J Saunders; R E Kirsch; J F Biebuyck
Journal:  J Neurochem       Date:  1979-02       Impact factor: 5.372

3.  Brain amino acids measured by intracerebral dialysis in portacaval shunted rats.

Authors:  U Tossman; S Eriksson; A Delin; L Hagenfeldt; D Law; U Ungerstedt
Journal:  J Neurochem       Date:  1983-10       Impact factor: 5.372

4.  Experimental studies of blood brain barrier permeability in acute hepatic failure.

Authors:  A E Zaki; R J Ede; M Davis; R Williams
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

5.  Regional cerebral glucose utilization in rats with portacaval anastomosis.

Authors:  A M Mans; J F Biebuyck; D W Davis; R M Bryan; R A Hawkins
Journal:  J Neurochem       Date:  1983-04       Impact factor: 5.372

6.  Metabolism of the inhibitory neurotransmitter gamma-aminobutyric acid in a rabbit model of fulminant hepatic failure.

Authors:  P Ferenci; D Covell; D F Schafer; J G Waggoner; R Shrager; E A Jones
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

7.  Colonic bacteria: a source of gamma-aminobutyric acid in blood.

Authors:  D F Schafer; J M Fowler; E A Jones
Journal:  Proc Soc Exp Biol Med       Date:  1981-07

8.  Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system.

Authors:  D F Schafer; E A Jones
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

9.  Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease.

Authors:  P Ferenci; D F Schafer; G Kleinberger; J H Hoofnagle; E A Jones
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

10.  Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy.

Authors:  J F Giguère; R F Butterworth
Journal:  Neurochem Res       Date:  1984-09       Impact factor: 3.996

View more
  4 in total

1.  Enhanced GABA release in cerebral cortical slices derived from rats with thioacetamide-induced hepatic encephalopathy.

Authors:  U Wysmyk; S S Oja; P Saransaari; J Albrecht
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

2.  Convulsions and wet-dog shakes produced by systemic or intrahippocampal administration of ruthenium red in the rat.

Authors:  G García-Ugalde; R Tapia
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 3.  The role of inhibitory amino acidergic neurotransmission in hepatic encephalopathy: a critical overview.

Authors:  Jan Albrecht; Magdalena Zielińska
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

4.  Biochemical and molecular modulation of CCl4-induced peripheral and central damage by Tilia americana var. mexicanaextracts.

Authors:  Elvia Coballase-Urrutia; Noemí Cárdenas-Rodríguez; María Carolina González-García; Eithan Núñez-Ramírez; Esaú Floriano-Sánchez; María Eva González-Trujano; Berenice Fernández-Rojas; José Pedraza-Chaverrí; Hortencia Montesinos-Correa; Liliana Rivera-Espinosa; Aristides Iii Sampieri; Liliana Carmona-Aparicio
Journal:  Saudi Pharm J       Date:  2016-07-12       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.